Clinical outcomes of drug-coated balloon in coronary lesions: a real-world, all-comers study.
Liang PanWenjie LuZhanying HanSancong PanXi WangYingguang ShanXule WangXiaolin ZhengRan LiYanjun ZhouPeng QinQiangwei ShiShuai ZhouWencai ZhangSen GuoPeisheng ZhangXiaofei QinGuoju SunZhongsheng QinZhenwen HuangChunguang QiuPublished in: Clinical research in cardiology : official journal of the German Cardiac Society (2021)
DCB angioplasty in this all-comers, real-world, prospective study was safe and efficient with low TLR and MACE rates. Thus, DCB appears to be an attractive alternative for the stent-less treatment of de novo coronary lesions. ISR in-stent restenosis; OR odds ratio; CI confidence interval; TLR target lesion revascularization; MACE major adverse cardiovascular events; MI myocardial infraction. MACE defined as the composite outcome of cardiac death, myocardial infarction, and target vessel revascularization. Any revascularization includes any percutaneous coronary intervention, and coronary artery bypass grafting.
Keyphrases
- coronary artery disease
- coronary artery bypass grafting
- cardiovascular events
- percutaneous coronary intervention
- st segment elevation myocardial infarction
- left ventricular
- toll like receptor
- st elevation myocardial infarction
- acute myocardial infarction
- antiplatelet therapy
- inflammatory response
- immune response
- heart failure
- coronary artery bypass
- coronary artery
- aortic stenosis
- nuclear factor
- acute coronary syndrome
- drug induced
- transcatheter aortic valve replacement
- replacement therapy